Terumo (TSE:4543) Valuation Rank


TSE:4543 Terumo Corp TSE:4543
88 GF Score
Price 円2,189.00
GF Value 円3,137.96
Valuation Significantly Undervalued
View Full Analysis

What is Terumo Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Terumo Valuation Rank Related Terms

TSE:4543
88GF Score
Terumo Corp TSE:4543
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Terumo (TSE:4543) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of 円2,189.00 is trading 30.2% below its estimated GF Value™ of 円3,137.96. GuruFocus considers Terumo to be Significantly Undervalued.

Key valuation signals for TSE:4543:

  • Valuation Rank:
  • GF Value™: 円3,137.96 vs. price of 円2,189.00 (30.2% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the TSE:4543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
88GF Score

Get the complete analysis for TSE:4543

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,189.00
Price
円3,137.96
GF Value